BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38238194)

  • 1. Intracystic injection of large surface area microparticle paclitaxel for chemoablation of intraductal papillary mucinous neoplasms: Insights from an expanded access protocol.
    Krishna SG; Ardeshna DR; Shah ZK; Hart PA; Culp S; Jones D; Chen W; Papachristou GI; Han S; Lee PJ; Shah H; Pawlik TM; Dillhoff M; Manilchuk A; Cloyd J JM; Ejaz A; Fry M; Noonan AM
    Pancreatology; 2024 Mar; 24(2):289-297. PubMed ID: 38238194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early phase trial of intracystic injection of large surface area microparticle paclitaxel for treatment of mucinous pancreatic cysts.
    Othman M; Patel K; Krishna SG; Mendoza-Ladd A; Verco S; Abidi W; Verco J; Wendt A; diZerega G
    Endosc Int Open; 2022 Dec; 10(12):E1517-E1525. PubMed ID: 36531683
    [No Abstract]   [Full Text] [Related]  

  • 3. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.
    Nguyen AH; Toste PA; Farrell JJ; Clerkin BM; Williams J; Muthusamy VR; Watson RR; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Gastrointest Surg; 2015 Feb; 19(2):258-65. PubMed ID: 25373706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Endoscopic Ultrasound-Guided Chemoablative Techniques for Pancreatic Cystic Lesions.
    Koehler B; Ryoo DY; Krishna SG
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.
    Wong J; Weber J; Centeno BA; Vignesh S; Harris CL; Klapman JB; Hodul P
    J Gastrointest Surg; 2013 Jan; 17(1):78-84; discussion p.84-5. PubMed ID: 22948841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory protein profiling of pancreatic cyst fluid using EUS-FNA in tandem with cytokine microarray differentiates between branch duct IPMN and inflammatory cysts.
    Lee LS; Banks PA; Bellizzi AM; Sainani NI; Kadiyala V; Suleiman S; Conwell DL; Paulo JA
    J Immunol Methods; 2012 Aug; 382(1-2):142-149. PubMed ID: 22683544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatitis is frequent among patients with side-branch intraductal papillary mucinous neoplasia diagnosed by EUS.
    Ringold DA; Shroff P; Sikka SK; Ylagan L; Jonnalagadda S; Early DS; Edmundowicz SA; Azar R
    Gastrointest Endosc; 2009 Sep; 70(3):488-94. PubMed ID: 19555941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.
    Muraki T; Jang KT; Reid MD; Pehlivanoglu B; Memis B; Basturk O; Mittal P; Kooby D; Maithel SK; Sarmiento JM; Christians K; Tsai S; Evans D; Adsay V
    Mod Pathol; 2022 Jan; 35(1):96-105. PubMed ID: 34518632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk of acute pancreatitis after endoscopic ultrasound-guided fine needle aspiration of side branch intraductal papillary mucinous neoplasms.
    Siddiqui AA; Shahid H; Shah A; Khurana T; Huntington W; Ghumman SS; Loren DE; Kowalski TE; Laique S; Hayat U; Eloubeidi MA
    Endosc Ultrasound; 2015; 4(2):109-14. PubMed ID: 26020044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
    Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
    Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of preoperative endoscopic procedures on adverse event rates after surgical resection for main-duct and mixed-type intraductal papillary mucinous neoplasms (IPMNs).
    Ni P; Mayo H; Fernández-Del Castillo C; Elamin S; Brown DR; Mino-Kenudson M; Krishnan K; Casey B; Lafaro K; Lennon AM; Afghani E; Hernandez-Barco YG
    Pancreatology; 2024 Feb; 24(1):152-159. PubMed ID: 37981524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy.
    Kwong WT; Lawson RD; Hunt G; Fehmi SM; Proudfoot JA; Xu R; Giap A; Tang RS; Gonzalez I; Krinsky ML; Savides TJ
    Dig Dis Sci; 2015 Sep; 60(9):2800-6. PubMed ID: 25924899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Pancreatitis Finding by Endoscopic Ultrasonography in the Pancreatic Parenchyma of Intraductal Papillary Mucinous Neoplasms Is Associated with Invasive Intraductal Papillary Mucinous Carcinoma.
    Takenaka M; Masuda A; Shiomi H; Yagi Y; Zen Y; Sakai A; Kobayashi T; Arisaka Y; Okabe Y; Kutsumi H; Toyama H; Fukumoto T; Ku Y; Kudo M; Azuma T
    Oncology; 2017; 93 Suppl 1():61-68. PubMed ID: 29258092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology.
    Pais SA; Attasaranya S; Leblanc JK; Sherman S; Schmidt CM; DeWitt J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):489-95. PubMed ID: 17350894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions: A single-center experience of 214 patients.
    Choi JH; Lee SH; Choi YH; You MS; Shin BS; Paik WH; Ryu JK; Kim YT
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):562-568. PubMed ID: 31551143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
    Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
    World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms.
    Smith LA; Mckay CJ
    Minerva Med; 2014 Oct; 105(5):413-21. PubMed ID: 25000220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.